ANTI-INFLAMMATORY EFFECTS OF THE CBP/P300 INHIBITOR A-485 ON THE MURINE CHONDROGENIC CELL LINE ATDC5 AND HUMAN DERMAL FIBROBLASTS. (April 2022)